(Q43754300)

26 November 2017

Immunotherapeutic strategies for cancer using poxvirus vectors (English)

1 reference

26 November 2017

1 reference

Paoletti E

1

1 reference

26 November 2017

Tartaglia J

series ordinal

2

1 reference

26 November 2017

Cox WI

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

Annals of the New York Academy of Sciences

26 November 2017

1 reference

26 November 2017

690

1 reference

26 November 2017

292-300

1 reference

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

26 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Immunotherapy of tumor-bearing mice utilizing virus help

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

New strategies for active immunotherapy with genetically engineered tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Molecular definition of tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Efficacy studies on a canarypox-rabies recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Immunisation with canarypox virus expressing rabies glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

Genetic basis for p53 overexpression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB44017.X

10.1111/J.1749-6632.1993.TB44017.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference